Meet the Team
About Us
Vascular Perfusion Solutions (VPS), a Texas-based early-stage Medtech company, is revolutionizing organ transplantation with a focus on simplicity, ease of use, and accessibility in price through our flagship product, the VP.S ENCORE®, a hypothermic machine perfusion device for prolonged cardiac graft preservation.
This innovative device represents a groundbreaking advancement in heart preservation technology, surpassing conventional methods such as the ice-cooler. It gained FDA Breakthrough Device Designation in 2021 and has undergone successful preclinical testing on over 100 hearts, including ovine, porcine, and human hearts donated for research.
Leadership
Rafael Veraza, PhD, MPh
Chief Executive Officer
Toni Hänninen
Interim CFO
Kristina Andrijauskaite, PhD, MS, MEd
Chief Scientific & Technology Officer
George Lamberson
Principal Mechanical Engineer
Team Members
Zachary Maxwell
Operations Manager
Chelbee Mendez
Senior Scientist
Riley Lopez
Quality Engineer
Exal Cisneros
Research Engineer
Maria Basurto
Electrical Engineer
Scientific & Clinical Advisory Board
Donald E. Ingber, MD, PhD
Founding Director, Wyss Institute for Biologically Inspired Engineering at Harvard University
Cristiano Amarelli, MD
Cardiothoracic, Surgeon, Naples Italy
Chair of Gordon Conference in Cardiac Preservation
Board of Directors for the European Society for Organ Transplantation
Co-Chair
Alexis E. Shafii, MD
Cardiothoracic, Surgeon, Baylor St. Luke’s Medical Center
Surgical director of the heart transplant program at Baylor St. Luke’s Medical Center
Co-Chair
Thomas C. Mayes, MD, MBA
Former President and CEO of UT Medicine SA
Medical Director of the Pediatric ICU's at University Hospital and CHRISTUS Santa Rosa Children's Hospital
Maj Gen Byron Hepburn, MD
Associate VP and Inaugural Director of the Military Health Institute at UT Health San Antonio
William (Billy) Cohn, MD
Cardiothoracic Surgeon
Executive Director at the Center for Device
Innovation at the Texas Medical Center in Houston
William Bauta, PhD
Senior Vice President of Research and Development, Therapeutics BioAffinity Technologies